Today on Outsourcing-Pharma.com   Quintiles in $3bn investment deal Merck divests API plant; hands out large contract IDM Pharma will cut jobs after Sanofi scraps melanoma collaboration eClinical news in Brief Fine Foods extends within pharma

Related Industry News   Mapping the 'human embryome' in BioTime Pfizer buys CovX to bulk biologics pipeline NIH cash for new tools to unravel genome's secrets Novozymes and Millipore to supply cell culture supplements

Breaking News on Outsourcing Pharma
Daily  Wednesday 02 January 2008		Forward to a colleague

	Access Full Stories Quintiles in $3bn investment deal One Equity Partners (OEP), the private equity arm of JPMorgan Chase, is in the process of selling its stake in Quintiles for a reported sum of over $3bn... Read Merck divests API plant; hands out large contract Merck & Co has handed the reins of one of its US active pharmaceutical ingredient (API) manufacturing facilities over to new a owner, who has also secured a lucrative contract manufacturing deal with the drug... Read IDM Pharma will cut jobs after Sanofi scraps melanoma collaboration Sanofi-Aventis has decided to pull out of its skin cancer collaboration with IDM Pharma, leaving the Californian biopharma firm considering job cuts as a way to lower costs... Read eClinical news in Brief Outsourcing-Pharma tracks the latest eClinical movements, featuring Medidata, Datatrak and ClinPhone... Read Fine Foods extends within pharma Italy's Fine Foods has purchased a domestic contract manufacturer operating in the pharmaceutical arena, extending its presence in this industry... Read
	All News Headlines for: January | December | November
	Related Industry News Mapping the 'human embryome' in BioTime BioTimes' subsidiary, Embryome Sciences, is planning to build a relational database that will help identify the hundreds of cell types that can be made from human and mouse embryonic stem cells... Read Pfizer buys CovX to bulk biologics pipeline Pfizer, the world's largest pharma firm, has reached into its pockets to buy CovX, a privately-held US biotech that specialises in combining the strengths of peptides and antibodies into new drugs... Read NIH cash for new tools to unravel genome's secrets The technology used to decipher an organism's gene sequence has come on in leaps and bounds this year. So much so that the US National Institutes of Health (NIH) has now released funds to create new tools to analyse... Read Novozymes and Millipore to supply cell culture supplements Novozymes and Millipore are to supply animal-free cell culture supplements to the biopharmaceutical industry... Read Annual round up of all drugs entering Phase I Small molecules still leading the way into the clinic DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007. Read Previous Headlines Small molecules still leading the way into the clinic DrugResearcher.com brings you its annual round up of all the drugs that entered clinical development in 2007... Read Consort Medical feeling the loss of Exubera Consort Medical's UK operations may be in line for more job losses as further collateral damage from Pfizer's withdrawal of Exubera from the market... Read Pharmaceutical outsourcing: people on the move Consort Medical, Quintiles, Covance and PPD have all had people on the move in the world of pharmaceutical outsourcing... Read Clinical contract news in brief Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving PPD, PRA, Accutest and Premier Research... Read Biopartners ends supply agreement with TMH Biopartners has terminated its supply agreement with The Medical House because of a go-slow in receiving functional drug delivery devices... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com